124
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Association Between Lipid Accumulation Product and Target Organ Damage in Elderly Population: The Northern Shanghai Study

, , , ORCID Icon, , , , , & show all
Pages 1769-1776 | Published online: 02 Oct 2021

References

  • Fox CS, Massaro M, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116(1):39–48. doi:10.1161/circulationaha.106.67535517576866
  • Preis SR, Massaro M, Robins SJ, et al. Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity (Silver Spring, Md). 2010;18(11):2191–2198. doi:10.1038/oby.2010.59
  • Camhi SM, Bray GA, Bouchard C, et al. The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: sex and race differences. Obesity (Silver Spring, Md). 2011;19(2):402–408. doi:10.1038/oby.2010.248
  • Shah RV, Murthy VL, Abbasi A, et al. Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA Study. JACC. 2014;7(12):1221–1235. doi:10.1016/j.jcmg.2014.07.017
  • Neeland IJ, Turer T, Ayers CR, et al. Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults. JAMA. 2012;308(11):1150–1159. doi:10.1001/2012.jama.1113222990274
  • Kahn HS. The “lipid accumulation product” performs better than the body mass index for recognizing cardiovascular risk: a population-based comparison. BMC Cardiovasc Disord. 2005;5:26. doi:10.1186/1471-2261-5-2616150143
  • Wiltgen D, Benedetto IG, Mastella LS, Spritzer PM. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome. Hum Reprod. 2009;24(7):1726–1731. doi:10.1093/humrep/dep07219329517
  • Oh J-Y, Sung Y-A, Lee HJ. The lipid accumulation product as a useful index for identifying abnormal glucose regulation in young Korean women. Diabetic Med. 2013;30(4):436–442. doi:10.1111/dme.1205223075457
  • Kahn HS. The lipid accumulation product is better than BMI for identifying diabetes: a population-based comparison. Diabetes Care. 2006;29(1):151–153. doi:10.2337/diacare.29.1.15116373916
  • Tellechea ML, Aranguren FA, Martinez-Larrad M, Serrano-Rios M, Taverna MJ, Frechtel GD. Ability of lipid accumulation product to identify metabolic syndrome in healthy men from Buenos Aires. Diabetes Care. 2009;32(7):e85. doi:10.2337/dc08-228419564464
  • Taverna MJT, Martínez-Larrad MT, Frechtel GD, Serrano-Ríos M. Lipid accumulation product: a powerful marker of metabolic syndrome in healthy population. Eur J Endocrinol. 2011;164(4):559–567. doi:10.1530/eje-10-103921262912
  • Ray L, Ravichandran K, Nanda SK. Comparison of lipid accumulation product index with body mass index and waist circumference as a predictor of metabolic syndrome in Indian Population. Metab Syndr Relat Disord. 2018;16(5):240–245. doi:10.1089/met.2017.011929648916
  • Brahimaj A, Rivadeneira F, Muka T, et al. Novel metabolic indices and incident type 2 diabetes among women and men: the Rotterdam Study. Diabetologia. 2019;62(9):1581–1590. doi:10.1007/s00125-019-4921-2.31183505
  • Wehr E, Gruber H-J, Giuliani A, Möller R, Pieber TR, Obermayer-Pietsch B. The lipid accumulation product is associated with impaired glucose tolerance in PCOS women. J Clin Endocrinol Metab. 2011;96(6):E986–90. doi:10.1210/jc.2011-003121470992
  • Ioachimescu AG, Brennan DM, Hoar BM, Hoogwerf BJ. The lipid accumulation product and all-cause mortality in patients at high cardiovascular risk: a PreCIS database study. Obesity (Silver Spring, Md). 2010;18(9):1836–1844. doi:10.1038/oby.2009.453
  • Schunkert H. Obesity and target organ damage: the heart. Int J Obes Rel Metab Disord. 2002;S15–20. doi:10.1038/sj.ijo.0802214
  • De Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL. Obesity and target organ damage: the kidney. Int J Obes Rel Metab Disord. 2002;S21–4. doi:10.1038/sj.ijo.0802213
  • Palatini P, Saladini F, Mos L, et al. Obesity is a strong determinant of hypertensive target organ damage in young-to-middle-age patients. Int J Obes. 2013;37(2):224–229. doi:10.1038/ijo.2012.32.
  • Fassini G, Conti S, Moltrasio M, et al. Concomitant cryoballoon ablation and percutaneous closure of left atrial appendage in patients with atrial fibrillation. Europace. 2016;18(11):1705–1710. doi:10.1093/europace/euw00727402623
  • Ji H, Xiong J, Yu S, et al. Northern Shanghai Study: cardiovascular risk and its associated factors in the Chinese elderly-a study protocol of a prospective study design. BMJ Open. 2017;7(3):e013880. doi:10.1136/bmjopen-2016-013880.
  • Beck GJ, Berg RL, Coggins C, et al. Design and statistical issues of the modification of diet in renal disease trial. The Modification of Diet in Renal Disease Study Group. Control Clin Trials. 1991;12(5):566–586. doi:10.1016/0197-2456(91)90069-x1664792
  • Roriz AKC, Passos LCS, de Oliveira CC, et al. Evaluation of the accuracy of anthropometric clinical indicators of visceral fat in adults and elderly. PLoS One. 2014;9(7):e103499. doi:10.1371/journal.pone.010349925078454
  • Ganguly S, Ray L, Kuruvila S, Nanda SK, Ravichandran K. Lipid accumulation product index as visceral obesity indicator in psoriasis: a case-control study. Indian J Dermatol. 2018;63(2):136–140. doi:10.4103/ijd.IJD_315_16.29692455
  • Rotter I, Rył A, Szylińska A, Pawlukowska W, Lubkowska A, Laszczyńska M. Lipid Accumulation Product (LAP) as an index of metabolic and hormonal disorders in aging men. Exp Clin Endocrinol Diabetes. 2017;125(3):176–182. doi:10.1055/s-0042-116071.27898988
  • Bozorgmanesh M, Hadaegh F, Azizi F. Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study. Lipids Health Dis. 2010;9(1):45. doi:10.1186/1476-511x-9-4520459710
  • Tian T, Pei H, Chen Z, et al. Comparison of lipid accumulation product and body mass index as indicators of diabetes diagnosis among 215,651 Chinese adults. Peer J. 2020;8:e8483. doi:10.7717/peerj.848332095339
  • Wang Z, He S, Chen X. Capacity of different anthropometric measures to predict diabetes in a Chinese population in southwest China: a 15-year prospective study. Diabetic Med. 2019;36(10):1261–1267. doi:10.1111/dme.1405531215075
  • Biyik Z, Guney IJ. Lipid accumulation product and visceral adiposity index: two new indices to predict metabolic syndrome in chronic kidney disease. Eur Rev Med Pharmacol Sci. 2019;23(5):2167–2173. doi:10.26355/eurrev_201903_17262.30915762
  • Wang H, Li Z, Guo X, et al. The impact of nontraditional lipid profiles on left ventricular geometric abnormalities in general Chinese population. BMC Cardiovasc Disord. 2018;18(1):88. doi:10.1186/s12872-018-0829-x29739326
  • Wang H, Sun Y, Li Z, et al. Gender-specific contribution of cardiometabolic index and lipid accumulation product to left ventricular geometry change in general population of rural China. BMC Cardiovasc Disord. 2018;18(1):62. doi:10.1186/s12872-018-0798-0.29631555
  • Wung C, Lee M, Wu P, Huang J, Chen S. Obesity-related indices are associated with peripheral artery occlusive disease in patients with Type 2 diabetes mellitus. J Pers Med. 2021;11(6):533. doi:10.3390/jpm1106053334207835
  • Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27(21):2588–2605. doi:10.1093/eurheartj/ehl25417000623
  • Lopes-Vicente WR, Rodrigues S, Cepeda FX, et al. Arterial stiffness and its association with clustering of metabolic syndrome risk factors. Diabetol Metab Syndr. 2017;9:87. doi:10.1186/s13098-017-0286-129090024
  • Topouchian J, Labat C, Gautier S, et al. Effects of metabolic syndrome on arterial function in different age groups: the Advanced Approach to Arterial Stiffness study. J Hypertens. 2018;36(4):824–833. doi:10.1097/hjh.000000000000163129324585
  • Zachariah J, Rong J, Larson M, et al. Metabolic predictors of change in vascular function: prospective associations from a community-based cohort. Hypertension (Dallas, Tex:1979). 2018;71(2):237–242. doi:10.1161/hypertensionaha.117.10054
  • Meani P, Maloberti A, Sormani P, et al. Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up. Blood Press. 2018;27(1):32–40. doi:10.1080/08037051.2017.137806928922954
  • Maloberti A, Rebora P, Andreano A, et al. Pulse wave velocity progression over a medium-term follow-up in hypertensives: focus on uric acid. J Clin Hypertens. 2019;21(7):975–983. doi:10.1111/jch.13603
  • Maloberti A, Bruno R, Facchetti R, et al. THE role of metabolic syndrome in blood pressure control and pulse wave velocity progression over a 3.5 years in treated hypertensive PATIENTS. Eur J Intern Med. 2020;76:107–109. doi:10.1016/j.ejim.2020.02.00532081529
  • Dai D, Chang Y, Chen Y, et al. Visceral adiposity index and lipid accumulation product index: two alternate body indices to identify chronic kidney disease among the Rural Population in Northeast China. Int J Environ Res Public Health. 2016;13:12. doi:10.3390/ijerph13121231
  • Zhang K, Li Q, Chen Y, Wang N, Lu Y. Visceral adiposity and renal function: an observational study from SPECT-China. Lipids Health Dis. 2017;16(1):205. doi:10.1186/s12944-017-0597-029078775
  • Liu Y, Wang Y, Wang J, et al. Lipid accumulation product is associated with urinary albumin-creatinine ratio in Chinese prediabetic population: a report from the REACTION Study. Diabetes Metab Syndr Obes. 2021;14:2415–2425. doi:10.2147/dmso.S31075134093028
  • Jx N, Mb C, de Sousa RML, et al. Importance of lipid accumulation product index as a marker of CVD risk in PCOS women. Lipids Health Dis. 2015;14:62. doi:10.1186/s12944-015-0061-y26104466
  • Wehr E, Pilz S, Boehm BO, März W, Obermayer-Pietsch B. The lipid accumulation product is associated with increased mortality in normal weight postmenopausal women. Obesity (Silver Spring, Md). 2011;19(9):1873–1880. doi:10.1038/oby.2011.42
  • Hosseinpanah F, Barzin M, Mirbolouk M, et al. Lipid accumulation product and incident cardiovascular events in a normal weight population: Tehran Lipid and Glucose Study. Eur J Prev Cardiol. 2016;23(2):187–193. doi:10.1177/2047487314558771.25381336
  • Maloberti A, Bombelli M, Vallerio P, et al. Metabolic syndrome is related to vascular structural alterations but not to functional ones both in hypertensives and healthy subjects. Nutri Metabol Cardiovasc Dis. 2021;31(4):1044–1052. doi:10.1016/j.numecd.2020.11.011